Comparison of CTrach, Intubating Laryngeal Mask Airway (ILMA) and I-gel for Tracheal Intubation

November 12, 2010 updated by: Northern Health and Social Care Trust

Position of Supraglottic Airway as a Conduit for Tracheal Intubation - A Comparison of CTrach, Intubating LMA and I-gel Supraglottic Airway

Various supraglottic airways may be used as a dedicated airway for insertion of intubating fibrescope and tracheal intubation in the patients with difficult to manage airways (Difficult Airway Society Guidelines).

The investigators aim to compare three different types of supraglottic device as a conduit for tracheal intubation - CTrach optical laryngeal mask, Intubating laryngeal mask airway and I-gel supraglottic airway. Null hypothesis for this study is that all three devices will perform without statistical difference in the means of success rate and time needed for their insertion and tracheal intubation.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Supraglottic airway devices such as I-LMa, Igel and LMA Ctrach are designed to create a "dedicated" airway which safely allows both spontaneous and controlled ventilation. The use of supraglottic airways can allow planned fibreoptic intubations in expected difficult cases and can provide an emergency airway in cases of unexpected difficult airway.

The ILMA (Intavent Orthofix Ltd.,Wokingham, UK) has been designed for either blind or fibrescope-guided tracheal intubation, in patients with expected and unexpected difficult airway. Since its development in 1997, it has been used for both blind and fibrescope-guided tracheal intubations in the patients with difficult airway. The ILMA is currently a 'gold standard' in supraglottic airways used for tracheal intubation.

The I-gel (Intersurgical Ltd., Wokingham, UK) is a newer dedicated airway device, which with its wide bore allows direct passage of a tracheal tube.

The CTrach (The Laryngeal Mask Company,Singapore) is a newer device for airway management. It has special optical fibres built-in inside its bowl and a liquid crystal display which allows views of the larynx while the endotracheal tube is being placed.

With reference to these supraglottic airway devices, only a small number of case reports detail tracheal intubation through an I-gel in patients with difficult airways. There have been manikin studies comparing ILMA and CTrach, and some descriptive studies on the use of CTrach in patients with predicted difficult airways- but no studies comparing the performance of these devices in clinical practice.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antrim, United Kingdom, BT41 2RL
        • Antrim Area Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 89 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA I-III patients
  • Age 18-89 years, males and females
  • Elective surgical patients needing tracheal intubation

Exclusion Criteria:

  • ASA IV or V patients
  • Emergency surgical procedures
  • Patients at increased risk of aspiration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: CTrach
  1. Induction to GA with 1mcg/kg fentanyl, and 1-3 mg/kg of propofol to loss of verbal contact and neuromuscular relaxation with 0.5 mg/kg of atracurium.
  2. Direct laryngoscopy, evaluation of laryngeal view grade according to Cormack-Lehane classification.
  3. Insertion of CTrach (sizes 3,4 or 5), establishment of ventilation.
  4. Direct evaluation of laryngeal view through CTrach
  5. Tracheal intubation through CTrach LMA
  6. Maintenance of anaesthesia with 02, air and sevoflurane 1-2 MAC and positive pressure ventilation
  7. At the end of surgery patient will be awoken as normal. Any sign of trauma to the oral cavity and airways and gastric fluid in trachea will be noted.
Insertion of a plastic tube under direct vision (built-in camera, intubating fibrescope) into trachea.
Other Names:
  • intubation
  • insertion of tracheal tube
ACTIVE_COMPARATOR: Intubating Laryngeal Mask Airway (ILMA)
  1. Induction to GA with 1mcg/kg fentanyl, and 1-3 mg/kg of propofol to loss of verbal contact and neuromuscular relaxation with 0.5 mg/kg of atracurium.
  2. Direct laryngoscopy, evaluation of laryngeal view grade according to Cormack-Lehane classification.
  3. Insertion of ILMA (sizes 3,4 or 5), establishment of ventilation.
  4. Evaluation of laryngeal view through ILMA using fibrescope
  5. Tracheal intubation through ILMA using fibrescope.
  6. Maintenance of anaesthesia with 02, air and sevoflurane 1-2 MAC and positive pressure ventilation
  7. At the end of surgery patient will be awoken as normal. Any sign of trauma to the oral cavity and airways and gastric fluid in trachea will be noted.
Insertion of a plastic tube under direct vision (built-in camera, intubating fibrescope) into trachea.
Other Names:
  • intubation
  • insertion of tracheal tube
ACTIVE_COMPARATOR: I-gel
  1. Induction to GA with 1mcg/kg fentanyl, and 1-3 mg/kg of propofol to loss of verbal contact and neuromuscular relaxation with 0.5 mg/kg of atracurium.
  2. Direct laryngoscopy, evaluation of laryngeal view grade according to Cormack-Lehane classification.
  3. Insertion of I-gel (sizes 3,4 or 5), establishment of ventilation.
  4. Evaluation of laryngeal view through I-gel using fibrescope
  5. Tracheal intubation through I-gel using fibrescope
  6. Maintenance of anaesthesia with 02, air and sevoflurane 1-2 MAC and positive pressure ventilation
  7. At the end of surgery patient will be awoken as normal. Any sign of trauma to the oral cavity and airways and gastric fluid in trachea will be noted.
Insertion of a plastic tube under direct vision (built-in camera, intubating fibrescope) into trachea.
Other Names:
  • intubation
  • insertion of tracheal tube

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Success rate of tracheal intubation (%)
Time Frame: After successful insertion of tracheal tube
After successful insertion of tracheal tube

Secondary Outcome Measures

Outcome Measure
Time Frame
Time needed for successful insertion of a supraglottic device
Time Frame: After insertion
After insertion
Total time needed for successful tracheal intubation through a device
Time Frame: After insertion
After insertion
Fibreoptic view following to supraglottic device insertion
Time Frame: After insertion of SGA
After insertion of SGA
Complication rate - sore throat, difficulty swallowing, hoarseness, numb tongue, nausea
Time Frame: at 1 h after operation, at 24 h
at 1 h after operation, at 24 h

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pavel Michalek, MD,PhD,DESA, Northern HSC Trust

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2009

Primary Completion (ACTUAL)

September 1, 2010

Study Completion (ACTUAL)

September 1, 2010

Study Registration Dates

First Submitted

September 23, 2009

First Submitted That Met QC Criteria

September 23, 2009

First Posted (ESTIMATE)

September 24, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

November 15, 2010

Last Update Submitted That Met QC Criteria

November 12, 2010

Last Verified

October 1, 2010

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe